cbdMD, Inc.

Equities

YCBD

US12482W3097

Pharmaceuticals

Market Closed - Nyse 04:10:00 2024-05-20 pm EDT 5-day change 1st Jan Change
0.7171 USD +0.23% Intraday chart for cbdMD, Inc. +4.69% -31.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Earnings Flash (YCBD) CBDMD Reports Q2 Revenue $4.4M MT
CbdMD, Inc. Appoints Brad Whitford as Chief Accounting Officer, Treasurer and Secretary CI
Transcript : CbdMD, Inc. - Shareholder/Analyst Call
Earnings Flash (YCBD) CBDMD Posts Q1 Revenue $5.4M MT
CbdMD, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
CbdMD, Inc. announced that it expects to receive $1.25 million in funding CI
Earnings Flash (YCBD) CBDMD Posts Q4 Revenue $24.2M MT
CbdMD, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
North American Morning Briefing : S&P 500 Futures Dip with Fresh Record in Sight DJ
North American Morning Briefing : Traders Await -2- DJ
Maxim Starts Coverage on cbdMD with Buy Rating, $3 Price Target MT
Transcript : CbdMD, Inc. - Shareholder/Analyst Call
CbdMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
Earnings Flash (YCBD) CBDMD Posts Q3 Revenue $6.1M MT
Transcript : CbdMD, Inc., Q3 2023 Earnings Call, Aug 10, 2023
Certain Restricted Stock Units of cbdMD, Inc. are subject to a Lock-Up Agreement Ending on 30-JUL-2023. CI
Certain Warrants of cbdMD, Inc. are subject to a Lock-Up Agreement Ending on 30-JUL-2023. CI
Certain Options of cbdMD, Inc. are subject to a Lock-Up Agreement Ending on 30-JUL-2023. CI
Certain Common Stock of cbdMD, Inc. are subject to a Lock-Up Agreement Ending on 30-JUL-2023. CI
Certain Series A Convertible Preferred Stock of cbdMD, Inc. are subject to a Lock-Up Agreement Ending on 30-JUL-2023. CI
CbdMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Earnings Flash (YCBD) CBDMD Posts Q2 Revenue $6.2M MT
Transcript : CbdMD, Inc., Q2 2023 Earnings Call, May 15, 2023
Top Midday Decliners MT
US Stocks Set to Open Relatively Flat Ahead of Manufacturing, Construction Spending Data MT
Chart cbdMD, Inc.
More charts
cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7171 USD
Average target price
2 USD
Spread / Average Target
+178.90%
Consensus
  1. Stock Market
  2. Equities
  3. YCBD Stock
  4. News cbdMD, Inc.
  5. Earnings Flash (YCBD) CBDMD Posts Q2 Revenue $6.2M
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW